Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-11-26
pubmed:abstractText
Animal models suggest a vasomotor role for the B1 kinin receptor in cardiovascular disease states. In patients with heart failure treated with angiotensin-converting enzyme inhibition (ACEi), or combined B1/B2 receptor antagonism, but not B2 receptor antagonism alone, causes vasoconstriction. However, B1 agonism has no effect on vasomotor or fibrinolytic function. Findings from transgenic animals lacking the B2 receptor suggest that these conflicting data may be explained by cross-talk between B1 and B2 receptors. We hypothesized that B1 stimulation causes vasodilatation and tissue plasminogen activator release in the human forearm when B2 receptor signaling is inhibited. Forearm blood flow was measured in 16 patients with heart failure receiving ACEi. In double-blinded crossover studies, intrabrachial Lys-[Leu8]-des-Arg9-bradykinin (B1 antagonist), lys-des-Arg9-bradykinin (B1 agonist), bradykinin (B2 agonist), and sodium nitroprusside (endothelium-independent vasodilator) were infused alone or with HOE-140 (B2 antagonist). HOE-140 did not affect basal vascular tone or t-PA release, but it abolished bradykinin-induced vasodilatation and t-PA release (P < 0.0001). Blood flow and t-PA release were unaffected by B1 agonism or antagonism in the presence and absence HOE-140. Our findings do not support a role for crosstalk between the B1 and B2 kinin receptors in the human peripheral circulation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1533-4023
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
52
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
438-44
pubmed:meshHeading
pubmed-meshheading:19033823-Adult, pubmed-meshheading:19033823-Aged, pubmed-meshheading:19033823-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:19033823-Blood Pressure, pubmed-meshheading:19033823-Bradykinin, pubmed-meshheading:19033823-Cross-Over Studies, pubmed-meshheading:19033823-Double-Blind Method, pubmed-meshheading:19033823-Female, pubmed-meshheading:19033823-Heart Failure, pubmed-meshheading:19033823-Humans, pubmed-meshheading:19033823-Infusions, Intra-Arterial, pubmed-meshheading:19033823-Kallidin, pubmed-meshheading:19033823-Middle Aged, pubmed-meshheading:19033823-Nitroprusside, pubmed-meshheading:19033823-Receptor, Bradykinin B1, pubmed-meshheading:19033823-Receptor, Bradykinin B2, pubmed-meshheading:19033823-Regional Blood Flow, pubmed-meshheading:19033823-Tissue Plasminogen Activator, pubmed-meshheading:19033823-Vasodilation
pubmed:year
2008
pubmed:articleTitle
Vascular B1 kinin receptors in patients with congestive heart failure.
pubmed:affiliation
Centre for Cardiovascular Science, University of Edinburgh, United Kingdom; and thedaggerDepartment of Cardiology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, United Kingdom. ninian.lang@ed.ac.uk
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't